Liping Jin

Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Author Correction: LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation.

Author Correction: LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation.

Journal: Cell discovery
Published: July 16, 2026

Development and validation of a skin health knowledge, attitudes, and behaviors questionnaire for the general population: a cross-sectional study.

Development and validation of a skin health knowledge, attitudes, and behaviors questionnaire for the general population: a cross-sectional study.

Journal: Frontiers in public health
Published: April 20, 2026

PU.1 drives psoriasis pathogenesis by promoting intermediate monocytes-to-M1 macrophage differentiation through Dectin-1 signaling.

PU.1 drives psoriasis pathogenesis by promoting intermediate monocytes-to-M1 macrophage differentiation through Dectin-1 signaling.

Journal: Journal of autoimmunity
Published: January 29, 2026

Integrated Multi-Omics Profiling Reveals That Highly Pyroptotic MDMs Contribute to Psoriasis Progression Through CXCL16.

Integrated Multi-Omics Profiling Reveals That Highly Pyroptotic MDMs Contribute to Psoriasis Progression Through CXCL16.

Journal: Biomedicines
Published: May 22, 2025

Dihydromyricetin exerts dual anti-acne actions by suppressing propionibacterium acnes proliferation and host inflammatory responses via TLR2/NF-κB/MAPK pathway inhibition.

Dihydromyricetin exerts dual anti-acne actions by suppressing propionibacterium acnes proliferation and host inflammatory responses via TLR2/NF-κB/MAPK pathway inhibition.

Journal: European journal of pharmacology
Published: March 14, 2025

LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation.

LZTR1 regulates epithelial MHC-I expression via NF-κB1 to modulate CD8+ T cells activation.

Journal: Cell discovery
Published: March 06, 2025

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.

Response to comment on 'Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study'.

Journal: Human vaccines & immunotherapeutics
Published: September 05, 2024

Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.

Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study.

Journal: Human vaccines & immunotherapeutics
Published: June 11, 2024

Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation.

Topical histone deacetylase inhibitor remetinostat improves IMQ-induced psoriatic dermatitis via suppressing dendritic cell maturation and keratinocyte differentiation and inflammation.

Journal: European journal of pharmacology
Published: June 05, 2024

SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis-Associated Tumor Cells by Remodeling the Lymph Node Microenvironment.

SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis-Associated Tumor Cells by Remodeling the Lymph Node Microenvironment.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 14, 2024

Corrigendum to 'Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.' [EClinicalMedicine 59 (2023) 101981].

Corrigendum to 'Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.' [EClinicalMedicine 59 (2023) 101981].

Journal: EClinicalMedicine
Published: August 10, 2023

BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma.

BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma.

Journal: Cell reports. Medicine
Published: August 07, 2023
Showing 1-12 of 21

Last Updated: 09/26/2026